Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

7.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

690
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
690
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

570
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
570

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Preclinical Evaluation of [<sup>18</sup>F]JNJ-1: A Novel Positron Emission Tomography Ligand Targeting AMPAR/TARP γ8.

Molecular imaging and biology·2026
Same author

Visual versus quantitative tau-PET Braak staging in Alzheimer's disease using [<sup>18</sup>F]MK6240.

European journal of nuclear medicine and molecular imaging·2026
Same author

Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Head-to-head comparison of plasma p-tau217 immunoassays for incipient Alzheimer's disease in community cohorts.

Alzheimer's research & therapy·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Mar 10, 2026

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space
14:19

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space

Published on: February 1, 2016

9.0K

Tau Positron Emission Tomography Imaging.

Hartmuth C Kolb1, José Ignacio Andrés2

  • 1Janssen Research and Development, Neuroscience Biomarkers, San Diego, California 92121.

Cold Spring Harbor Perspectives in Biology
|December 13, 2016
PubMed
Summary
This summary is machine-generated.

Positron emission tomography (PET) imaging of neurofibrillary tangles (NFTs) shows promise for early Alzheimer's disease (AD) diagnosis. This review explores tau PET tracers for improved AD staging and therapeutic development.

More Related Videos

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
08:36

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

783
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 10, 2026

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space
14:19

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space

Published on: February 1, 2016

9.0K
Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
08:36

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

783
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K

Area of Science:

  • Neuroscience
  • Radiochemistry
  • Medical Imaging

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia in the elderly.
  • Neurofibrillary tangles (NFTs) correlate with cognitive decline severity in AD.
  • Noninvasive imaging is crucial for early AD diagnosis and staging.

Purpose of the Study:

  • To review the structural diversity of tau PET tracers for Alzheimer's disease.
  • To discuss challenges in developing high-affinity and selective NFT ligands.
  • To highlight recent advancements in clinical development of tau PET radioligands.

Main Methods:

  • Review of existing literature on tau PET tracers.
  • Analysis of structural properties of NFT ligands.
  • Assessment of clinical progress in tau PET radioligand development.

Main Results:

  • Tau PET imaging offers potential for early AD diagnosis and staging.
  • Development of selective NFT ligands remains a challenge.
  • Significant progress has been made in clinical tau PET radioligand development.

Conclusions:

  • Tau PET imaging is a promising tool for Alzheimer's disease management.
  • Further research is needed to overcome challenges in tracer development.
  • Advancements in tau PET tracers could facilitate disease-modifying therapeutics for AD.